SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001395064-19-000005
Filing Date
2019-06-27
Accepted
2019-06-27 06:41:08
Documents
193
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 20-F takeda20-f.htm 20-F 6197694
2 EXHIBIT 2.5 exhibit25.htm EX-2.5 80445
3 EXHIBIT 2.13 exhibit213.htm EX-2.13 47773
4 EXHIBIT 2.15 exhibit215.htm EX-2.15 55245
5 EXHIBIT 2.20 exhibit220.htm EX-2.20 25435
6 EXHIBIT 12.1 exhibit121.htm EX-12.1 10424
7 EXHIBIT 12.2 exhibit122.htm EX-12.2 10181
8 EXHIBIT 13.1 exhibit131.htm EX-13.1 3900
9 EXHIBIT 13.2 exhibit132.htm EX-13.2 3831
  Complete submission text file 0001395064-19-000005.txt   32639284

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT tak-20190331.xml EX-101.INS 9379486
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tak-20190331.xsd EX-101.SCH 213246
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tak-20190331_cal.xml EX-101.CAL 272470
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tak-20190331_def.xml EX-101.DEF 898959
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tak-20190331_lab.xml EX-101.LAB 2091563
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tak-20190331_pre.xml EX-101.PRE 1285284
Mailing Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
Business Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 20-F | Act: 34 | File No.: 001-38757 | Film No.: 19922921
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences